Breaking News Instant updates and real-time market news.

ABT

Abbott

$40.29

-0.88 (-2.14%)

10:50
10/19/16
10/19
10:50
10/19/16
10:50

Abbot call sale closes recently opened position for a loss

Abbot call sale closes recently opened position for a loss. Shares off 2% after earnings with 10K Nov 44 calls sold from 12c down to a dime in flow that may close a block of similar size opened Monday from 43 to 45c with shares 60c higher than current level.

  • 19

    Oct

  • 21

    Oct

  • 06

    Nov

ABT Abbott
$40.29

-0.88 (-2.14%)

09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
ADAM
09/29/16
NO CHANGE
Target $53
ADAM
Buy
Alere risk-reward looks 'quite good' as deal debate nears end, says Canaccord
Canaccord analyst Mark Massaro said he is optimistic that a conclusion of Abbott (ABT) and Alere's (ALR) merger fight is "not far off" and he still believes Abbott will ultimately acquire Alere, though he also thinks the merger may be decided by a judge. Massaro puts a 65% probability on the likelihood the deal closes at the $56 deal price, a 30% chance that Abbott buys Alere at a lower price nearer to $50 per share, and only a 5% chance the deal breaks, making the risk-reward ratio in Alere shares at current levels "quite good," he tells investors. He trimmed his price target on Alere to $53 from $56 an keeps a Buy rating on the stock.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.

TODAY'S FREE FLY STORIES

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

15:38
09/21/17
09/21
15:38
09/21/17
15:38
Hot Stocks
Sanderson Farms up regular dividend to 32c, declares special dividend of $1.00 »

Sanderson Farms announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

15:36
09/21/17
09/21
15:36
09/21/17
15:36
Hot Stocks
Breaking Hot Stocks news story on Sanderson Farms »

Sanderson Farms declares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

15:36
09/21/17
09/21
15:36
09/21/17
15:36
Hot Stocks
Breaking Hot Stocks news story on Sanderson Farms »

Sanderson Farms raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$98.12

1.92 (2.00%)

15:31
09/21/17
09/21
15:31
09/21/17
15:31
Recommendations
Intercept analyst commentary  »

Intercept selloff and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIK

Michaels

$21.42

-0.03 (-0.14%)

15:30
09/21/17
09/21
15:30
09/21/17
15:30
Options
Bullish flow continues for a third day in Michaels Companies »

Bullish flow continues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
09/21/17
09/21
15:17
09/21/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
09/21/17
09/21
15:16
09/21/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
09/21/17
09/21
15:15
09/21/17
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

15:10
09/21/17
09/21
15:10
09/21/17
15:10
General news
Fedspeak is heavy next week, with 12 Committee members scheduled »

Fedspeak is heavy next…

CSX

CSX

$52.81

1.03 (1.99%)

15:05
09/21/17
09/21
15:05
09/21/17
15:05
Hot Stocks
CSX says service 'rapidly' restored following Hurricane Irma »

CSX said that following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Oct

  • 30

    Oct

GE

General Electric

$24.65

0.33 (1.36%)

15:05
09/21/17
09/21
15:05
09/21/17
15:05
Options
General Electric call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

ICPT

Intercept

$98.12

1.92 (2.00%)

15:00
09/21/17
09/21
15:00
09/21/17
15:00
Downgrade
Intercept rating change  »

Intercept downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$13.70

-0.46 (-3.25%)

14:57
09/21/17
09/21
14:57
09/21/17
14:57
Periodicals
Snap cuts headcount at hardware lab, maker of spectacles, Bloomberg says »

According to the report,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YELP

Yelp

$43.73

-0.44 (-1.00%)

14:55
09/21/17
09/21
14:55
09/21/17
14:55
Options
Yelp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

14:55
09/21/17
09/21
14:55
09/21/17
14:55
General news
Canada CPI preview »

Canada CPI preview: CPI,…

14:50
09/21/17
09/21
14:50
09/21/17
14:50
General news
Canada retail sales preview »

Canada retail sales…

ICPT

Intercept

$98.12

1.92 (2.00%)

14:49
09/21/17
09/21
14:49
09/21/17
14:49
Recommendations
Intercept analyst commentary  »

Citi calls FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:45
09/21/17
09/21
14:45
09/21/17
14:45
Conference/Events
Cowen retail analyst hold an analyst/industry conference call »

Retailing/Specialty…

PSTG

Pure Storage

$15.32

0.49 (3.30%)

14:45
09/21/17
09/21
14:45
09/21/17
14:45
Options
Pure Storage call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

NLSN

Nielsen

$40.48

0.06 (0.15%)

, CBS

CBS

$58.90

-0.155 (-0.26%)

14:44
09/21/17
09/21
14:44
09/21/17
14:44
Hot Stocks
CBS to use Nielsen Out-of-Home Reporting Service »

Nielsen (NLSN) announced…

NLSN

Nielsen

$40.48

0.06 (0.15%)

CBS

CBS

$58.90

-0.155 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Nov

ALNY

Alnylam

14:41
09/21/17
09/21
14:41
09/21/17
14:41
Hot Stocks
Alnylam CEO 'confident' patisiran is best-in-class treatment »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESRX

Express Scripts

$61.82

0.82 (1.34%)

, NVS

Novartis

$85.01

-0.77 (-0.90%)

14:41
09/21/17
09/21
14:41
09/21/17
14:41
Hot Stocks
Express Scripts CMO discusses 'great promise, big price' of gene therapy »

In a post to the…

ESRX

Express Scripts

$61.82

0.82 (1.34%)

NVS

Novartis

$85.01

-0.77 (-0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 22

    Sep

  • 25

    Oct

  • 08

    Nov

  • 17

    May

ALNY

Alnylam

$113.84

38.8 (51.71%)

14:40
09/21/17
09/21
14:40
09/21/17
14:40
Hot Stocks
Alnylam CEO says more confident in other trials after patisiran data »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTX

Minerals Technologies

$69.50

1.1 (1.61%)

14:33
09/21/17
09/21
14:33
09/21/17
14:33
Hot Stocks
Minerals Technologies authorizes $150M, two-year share repurchase program »

Minerals Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$48.01

-0.345 (-0.71%)

14:30
09/21/17
09/21
14:30
09/21/17
14:30
Options
Short-term put buying in Harley Davidson »

Short-term put buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.